Caffeine Citrate Combined with Pulmonary Surfactant and Nasal Continuous Positive Airway Pressure in the Treatment of Premature Infants with Respiratory Distress Syndrome
返回论文页
|更新时间:2022-11-03
|
Caffeine Citrate Combined with Pulmonary Surfactant and Nasal Continuous Positive Airway Pressure in the Treatment of Premature Infants with Respiratory Distress Syndrome
Wu Qi. Caffeine Citrate Combined with Pulmonary Surfactant and Nasal Continuous Positive Airway Pressure in the Treatment of Premature Infants with Respiratory Distress Syndrome. [J]. 27(8):14-16(2021)
DOI:
Wu Qi. Caffeine Citrate Combined with Pulmonary Surfactant and Nasal Continuous Positive Airway Pressure in the Treatment of Premature Infants with Respiratory Distress Syndrome. [J]. 27(8):14-16(2021) DOI: 10.13407/j.cnki.jpp.1672.108X.2021.08.004.
Caffeine Citrate Combined with Pulmonary Surfactant and Nasal Continuous Positive Airway Pressure in the Treatment of Premature Infants with Respiratory Distress Syndrome
Objective: To probe into the application value of caffeine citrate in premature infants with respiratory distress syndrome (RDS). Methods: Clinical data of 190 cases of premature infants with RDS admitted to our hospital from Mar. 2017 to Mar. 2018 were retrospectively analyzed and divided into the control group (n=86) and the observation group (n=104) according to different treatment regimen. The control group was given pulmonary surfactant (PS) and nasal continuous positive airway pressure (nCPAP)
while the observation group received caffeine citrate combined with PS and nCPAP. After 3 d of treatment
the efficacy of two groups was compared. Results: There were no deaths during treatment in both groups. The effective rate of the observation group was 92.31%
higher than 81.40% of the control group (P<0.05). The mechanical ventilation time and length of stay in the observation group were shorter than those in the control group (P<0.01). After 3 d of treatment
the blood oxygen partial pressure (PaO2) and pH in both groups increased
and the observation group was higher than the control group (P<0.01)
the partial pressure of carbon dioxide (PaCO2) decreased
and the observation group was lower than the control group (P<0.01). There was no significant difference in the incidence of complications between two groups (P>0.05). Conclusion: Caffeine citrate combined with PS and nCPAP in the treatment of premature infants with RDS can enhance the curative effect and shorten the mechanical ventilation time and length of stay
Clinical Efficacy of Nasal Duo Positive Airway Pressure Combined with Less Invasive Pulmonary Surfactant Administration Technique in the Treatment of Premature Infants with Respiratory Distress Syndrome
Meta-Analysis on Efficacy of Porcine and Bovine Pulmonary Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome
Meta-Analysis of Efficacy and Safety of Different Drug Administration Routes for the Treatment of Premature Infants with Patent Ductus Arteriosus
Systematically Review on Effect of Caffeine at Different Starting Times on Prevention and Treatment of Apnea in Very Low Birth Weight Preterm Infants
A Case of Premature Infant with Cholestasis Induced by Drugs
Related Author
Zhang Huimin
Kang Jianing
Li Yuanzheng
Jia Meiyun
Liang Guijuan
Yan Anping
Liu Yanhong
Ling Baotian
Related Institution
Zhengzhou People’s Hospital
Yongchuan Hospital of Chongqing Medical University
Basic Medical College of Qingdao University
Children’ s Hospital of Chongqing Medical University
Children’ s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics